Cyclacel Pharmaceuticals to Present at the 22nd Annual ROTH Capital OC Growth Stock Conference
March 08, 2010 10:04 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., March 8, 2010 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company") today announced that the Company will present at the...
New Study in Clinical Cancer Research Demonstrates Potential for Cyclacel's Seliciclib in Treating Breast Cancer Resistant to Hormone Therapy
February 17, 2010 07:00 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., Feb. 17, 2010 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) today announced that a newly published study demonstrates that the company's...
Cyclacel Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference
February 01, 2010 07:00 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., Feb. 1, 2010 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (“Cyclacel” or the “Company”) today announced that the...
Cyclacel Regains NASDAQ Compliance
January 27, 2010 07:00 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., Jan. 27, 2010 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company") today announced that NASDAQ notified the Company...
Cyclacel Completes Previously Announced Registered Direct Offering
January 25, 2010 16:01 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., Jan. 25, 2010 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company") announced today that it completed its...
Cyclacel to Raise Up to $7.9 Million in Registered Direct Offering
January 21, 2010 09:21 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., Jan. 21, 2010 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (“Cyclacel” or the “Company”) announced today that it has...
Cyclacel Completes Previously Announced Registered Direct Offering
January 13, 2010 13:36 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., Jan. 13, 2010 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company") announced today that it completed its previously...
Cyclacel to Raise Up to $9.5 Million in Registered Direct Offering
January 11, 2010 09:10 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., Jan. 11, 2010 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company") announced today that it has entered into definitive...
Cyclacel's Seliciclib Found Effective Against Lung Cancer Cell Lines Including K-RAS Mutations
January 07, 2010 12:08 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., Jan. 7, 2010 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) today announced the publication of two peer-reviewed journal articles featuring the...
Cyclacel Pharmaceuticals to Present at OneMedForum 2010
January 06, 2010 07:00 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., Jan. 6, 2010 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) announced today that Spiro Rombotis, President and Chief Executive Officer, will...